Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
142.00
+1.51 (+1.07%)
Streaming Delayed Price
Updated: 12:15 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sarepta Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
Via
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
Via
Benzinga
Sarepta Therapeutics Stock Showing Rising Relative Strength
October 09, 2023
Sarepta Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
5 Analysts Have This to Say About Sarepta Therapeutics
September 26, 2023
Via
Benzinga
Is Sarepta Therapeutics Stock a Top Growth Vehicle?
August 23, 2023
An upcoming data readout could fuel another rally in the biotech's shares.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
Via
Benzinga
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via
Benzinga
Analyst Ratings for Sarepta Therapeutics
August 03, 2023
Via
Benzinga
Earnings Preview: Sarepta Therapeutics
August 01, 2023
Via
Benzinga
2 Biotech Growth Stocks I'd Buy Right Now
July 27, 2023
Both drugmakers seem to have a bright future ahead.
Via
The Motley Fool
Where Sarepta Therapeutics Stands With Analysts
July 14, 2023
Via
Benzinga
2 Top Growth Stocks to Buy With $500
September 14, 2023
No need to break the bank to invest in stocks.
Via
The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
August 22, 2023
Helping save and improve patients' lives in novel ways can be a lucrative activity.
Via
The Motley Fool
Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
August 15, 2023
Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades.
Via
Benzinga
$3M Bet On Tidewater? Check Out These 4 Stocks Insiders Are Buying
August 14, 2023
Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript
August 02, 2023
SRPT earnings call for the period ending June 30, 2023.
Via
The Motley Fool
3 Biotech Stocks to Sell Before They Damage Your Portfolio
July 12, 2023
With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point.
Via
InvestorPlace
What 25 Analyst Ratings Have To Say About Sarepta Therapeutics
June 23, 2023
Via
Benzinga
Sarepta Wins FDA Approval For Highly Anticipated Gene Therapy
June 22, 2023
Sarepta will sell the Duchenne muscular dystrophy gene therapy under the brand name Elevidys.
Via
Investor's Business Daily
Sarepta Therapeutics' Stock Is Down 14% in 1 Month, So Why Does Wall Street Expect It to Rise 65%?
June 30, 2023
While its gene therapy for Duchenne muscular dystrophy has been conditionally approved, it'll take a while to prove its merit.
Via
The Motley Fool
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 23, 2023
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2023
June 23, 2023
Via
Benzinga
Canopy Growth, Avadel Pharmaceuticals And Other Big Stocks Moving Lower On Friday
June 23, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session. GSR II Meteora Acquisition Corp. (NASDAQ: GSRM)...
Via
Benzinga
Sarepta Therapeutics' Therapy Becomes First To Score FDA Nod For Duchenne Muscular Dystrophy Gene Therapy
June 22, 2023
The FDA has granted accelerated approval to closely watched Sarepta Therapeutics Inc's (NASDAQ: SRPT) gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) in ambulatory pediatric patients aged...
Via
Benzinga
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
Baird has initiated coverage on RegenXbio Inc (NASDAQ: RGNX) with an Outperform rating and a
Via
Benzinga
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon
June 12, 2023
These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.